BEI
CVS icon

Benjamin Edwards Inc’s CVS Health CVS Stock Holding History

Benjamin Edwards Inc’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.68M Buy
45,247
+11,173
+33% +$997K 0.04% 362
2026
Q1 		$2.45M Buy
34,074
+9,050
+36% +$697K 0.02% 488
2025
Q4 		$1.99M Sell
25,024
-1,242
-5% -$97.9K 0.02% 504
2025
Q3 		$1.98M Sell
26,266
-5,131
-16% -$352K 0.02% 490
2025
Q2 		$2.17M Sell
31,397
-1,413
-4% -$92.7K 0.03% 442
2025
Q1 		$2.22M Buy
32,810
+4,182
+15% +$250K 0.03% 396
2024
Q4 		$1.29M Sell
28,628
-7,209
-20% -$404K 0.02% 538
2024
Q3 		$2.25M Buy
35,837
+30,308
+548% +$1.77M 0.03% 411
2024
Q2 		$327K Sell
5,529
-766
-12% -$47.9K 0.06% 274
2024
Q1 		$502K Buy
6,295
+1,942
+45% +$148K 0.1% 220
2023
Q4 		$344K Buy
4,353
+418
+11% +$29.8K 0.08% 236
2023
Q3 		$275K Sell
3,935
-261
-6% -$18.5K 0.07% 238
2023
Q2 		$290K Sell
4,196
-2,911
-41% -$207K 0.07% 223
2023
Q1 		$528K Sell
7,107
-2,123
-23% -$178K 0.13% 174
2022
Q4 		$860K Sell
9,230
-5,228
-36% -$504K 0.23% 128
2022
Q3 		$1.38M Buy
14,458
+427
+3% +$42.3K 0.41% 69
2022
Q2 		$1.3M Buy
14,031
+2,095
+18% +$204K 0.38% 81
2022
Q1 		$1.21M Buy
11,936
+4,705
+65% +$494K 0.35% 83
2021
Q4 		$746K Buy
7,231
+3,938
+120% +$364K 0.24% 114
2021
Q3 		$279K Buy
3,293
+3,060
+1,313% +$256K 0.17% 153
2021
Q2 		$19K Buy
233
+215
+1,194% +$17.6K 0.01% 332
2021
Q1 		$1K Buy
+18
New +$1.31K ﹤0.01% 370
2020
Q3 		– Sell
-109
Closed -$7K – 359
2020
Q2 		$7K Sell
109
-205
-65% -$12.9K 0.01% 310
2020
Q1 		$19K Buy
+314
New +$21K 0.02% 245
2019
Q3 		– Sell
-115
Closed -$6K – 302
2019
Q2 		$6K Hold
115
– – 0.01% 254
2019
Q1 		$6K Buy
+115
New +$7.1K 0.03% 234

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Benjamin Edwards Inc's CVS Position: Q2 2026 in Review

Benjamin Edwards Inc increased its CVS Health (CVS) stake by 33% in Q2 2026, buying an estimated $997K and bringing the position to 45,247 shares worth $4.68M. The position accounts for 0.04% of the portfolio, ranked #362.

Benjamin Edwards Inc first reported a position in CVS in Q1 2019 and has held it in 26 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Benjamin Edwards Inc held 45,247 shares of CVS Health worth $4.68M as of Q2 2026.
  • Benjamin Edwards Inc bought 11,173 CVS Health shares in Q2 2026, an estimated $997K.
  • CVS Health made up 0.04% of Benjamin Edwards Inc's portfolio in Q2 2026, its #362 holding.
  • Benjamin Edwards Inc first reported a position in CVS Health in Q1 2019 and has held it in 26 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Benjamin Edwards Inc's 13F filing for Q2 2026, filed 24 Jul 2026.